Dyspnea, or shortness of breath, is a common symptom encountered in medical practice. Its underlying causes are diverse, making it a challenging symptom to manage. This article aims to provide a comprehensive approach to dyspnea, aiding healthcare professionals in its effective diagnosis and management.
Dyspnea is a subjective experience, often described as an uncomfortable awareness of breathing. It can be caused by cardiac, pulmonary, metabolic, or psychological conditions. Understanding the pathophysiological mechanisms behind dyspnea is crucial in identifying its cause.
A thorough history and physical examination are pivotal in the evaluation of dyspnea. Assessing the onset, duration, severity, and associated symptoms can provide valuable clues. Physical examination should focus on the cardiovascular and respiratory systems, but should also include other systems based on the patient's history.
Initial investigations should include a complete blood count, chest X-ray, and electrocardiogram. Depending on the clinical suspicion, further investigations such as pulmonary function tests, echocardiogram, or computed tomography scan may be warranted. The goal is to identify the underlying cause and guide management.
Management of dyspnea is tailored to the underlying cause. This may range from medication for conditions such as asthma or heart failure, to non-pharmacological measures like pulmonary rehabilitation or cognitive-behavioral therapy. Patient education and reassurance are essential components of management.
Dyspnea is a complex symptom requiring a comprehensive clinical approach for effective management. By understanding its underlying mechanisms, conducting a thorough assessment, and tailoring management to the identified cause, healthcare professionals can significantly improve patient outcomes.
1.
Discovery reveals protein involved in Parkinson's disease also drives skin cancer
2.
The prognosis of the Slovakian PM; Kate Middleton's treatment; and drug test cheating.
3.
We Don't Always Know What's 'Best' for Our Patients
4.
New tumor therapy approach reduces costs and side effects while increasing accessibility
5.
Dual-action mRNA vaccine takes aim at aggressive skin cancer
1.
The Evolving Arsenal: A 2025 Review of Antibody-Drug Conjugates and the Future of Precision Oncology
2.
Case Study: Combining Targeted Therapy with Immunotherapy for Metastatic Melanoma
3.
Anion Gap: The Simple Calculation That Reveals Much About Your Health
4.
Contemporary Methods in Hematology Across Clinical Settings
5.
Unlocking the Potential of Cytarabine: A New Era of Cancer Treatment
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
2.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VI
3.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Further Talks
4.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option
5.
Current Scenario of Cancer- Palliative Care to Close the Care Gap
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation